CNS-induced natriuresis, neurohypophyseal peptides and renal dopamine and noradrenaline excretion in prehypertensive salt-sensitive Dahl rats.
To identify defects in the salt-sensitive Dahl rat (Dahl-S), the natriuretic, catecholaminergic and pressor responses to 60-min elevation of the cerebroventricular sodium concentration (CNS-induced natriuresis) were compared between prehypertensive salt-sensitive Dahl-S and salt-resistant Dahl rats (Dahl-R). The plasma concentrations of the rat natriuretic hormone oxytocin, which has implications for the development of hypertension, and vasopressin (AVP) were also measured. Basal sodium and catecholamine excretion and mean arterial blood pressure (MAP) were similar in both strains. Sodium excretion during CNS stimulation increased more than 15-fold in Dahl-R but only 10-fold in Dahl-S. Dopamine excretion increased only transiently and similarly in both strains. Noradrenaline excretion and response to CNS stimulation were similar, suggesting a comparable sympathetic nervous activity between the strains. MAP increased comparably in Dahl-R and Dahl-S. Plasma AVP concentration was similar in both strains while plasma oxytocin concentration after CNS stimulation was more than 2-fold higher in Dahl-S than in Dahl-R. In conclusion, the prehypertensive Dahl-S has an attenuated natriuretic response to elevations of the cerebroventricular fluid sodium concentration and a higher plasma level of the natriuretic hormone oxytocin. Dopamine is not a mediator of CNS-induced natriuresis in neither strain. The attenuated natriuretic response may partly explain the salt-sensitivity in Dahl-S, and the higher plasma oxytocin value may either represent an effort to compensate for the deficient natriuretic response or reflect a primary defect in this system. Due to the known involvement of oxytocin in central MAP regulation in some hypertensive animal models, the findings warrant further investigation.
Sjöquist
Mats
M
Section of Integrative Physiology, Department of Medical Cell Biology, Biomedical Center, University of Uppsala, Uppsala, Sweden.
Lee
Siu-Lan
SL
Hansell
Peter
P
D015102:3,4-Dihydroxyphenylacetic Acid / Q000652:urine; D000818:Animals; D002555:Cerebrospinal Fluid / Q000502:physiology*; D004298:Dopamine / Q000652:urine*; D006973:Hypertension / Q000503:physiopathology; D008297:Male; D009318:Natriuresis / Q000502:physiology*; D009638:Norepinephrine / Q000652:urine*; D010121:Oxytocin / Q000097:blood*; D051381:Rats; D020303:Rats, Inbred Dahl; D012462:Saline Solution, Hypertonic / Q000494:pharmacology; D012964:Sodium / Q000652:urine; D014667:Vasopressins / Q000097:blood
D012462:Saline Solution, Hypertonic; D015102:3,4-Dihydroxyphenylacetic Acid; D014667:Vasopressins; D010121:Oxytocin; D012964:Sodium; D004298:Dopamine; D009638:Norepinephrine